Excitingly, we demonstrate in our diet induced obesity mouse model that neutralising ADAM19 therapy results in weight loss, improves insulin sensitivity, and reduces liver TNF-α levels. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.